GSK-2336805 is a HCV NS5A inhibitor. GSK2336805 retained activity on chimeric replicons containing NS5A patient sequences from genotype 1 and patient and consensus sequences for genotypes 4 and 5 and part of genotype 6.

1256390-53-0

C42H52N8O8

796.91

GSK 2336805;JNJ-56914845;GSK805;GSK-805;GSK-2336805;GSK2336805

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years